These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18780833)

  • 1. Protection from graft-versus-host disease with a novel B7 binding site-specific mouse anti-mouse CD28 monoclonal antibody.
    Beyersdorf N; Ding X; Blank G; Dennehy KM; Kerkau T; Hünig T
    Blood; 2008 Nov; 112(10):4328-36. PubMed ID: 18780833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potent control of acute graft-versus-host disease lethality after immunization with a novel DNA vaccine targeted to B7-1/CD28 costimulatory signaling pathway.
    Luo Y; Liang F; Liu N; Xue H; Song X; Yuan F; Long J; Zhao X; Sun Y; Xi Y
    J Immunother; 2013 Feb; 36(2):82-92. PubMed ID: 23377669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Superagonistic CD28 stimulation of allogeneic T cells protects from acute graft-versus-host disease.
    Beyersdorf N; Ding X; Hünig T; Kerkau T
    Blood; 2009 Nov; 114(20):4575-82. PubMed ID: 19721011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antagonistic and agonistic anti-canine CD28 monoclonal antibodies: tools for allogeneic transplantation.
    Graves SS; Stone DM; Loretz C; Peterson LJ; Lesnikova M; Hwang B; Georges GE; Nash R; Storb R
    Transplantation; 2011 Apr; 91(8):833-40. PubMed ID: 21343872
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superantigen responses and co-stimulation: CD28 and CTLA-4 have opposing effects on T cell expansion in vitro and in vivo.
    Krummel MF; Sullivan TJ; Allison JP
    Int Immunol; 1996 Apr; 8(4):519-23. PubMed ID: 8671638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential graft-versus-leukaemia effect by CD28 and CD40 co-stimulatory blockade after graft-versus-host disease prophylaxis.
    Ohata J; Sakurai J; Saito K; Tani K; Asano S; Azuma M
    Clin Exp Immunol; 2002 Jul; 129(1):61-8. PubMed ID: 12100023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD28-specific antibody prevents graft-versus-host disease in mice.
    Yu XZ; Bidwell SJ; Martin PJ; Anasetti C
    J Immunol; 2000 May; 164(9):4564-8. PubMed ID: 10779758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aggressive skin allograft rejection in CD28-/- mice independent of the CD40/CD40L costimulatory pathway.
    Ha J; Bingaman AW; Durham MM; Pearson TC; Larsen CP
    Transpl Immunol; 2001 Oct; 9(1):13-7. PubMed ID: 11680567
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting of inducible costimulator (ICOS) expressed on alloreactive T cells down-regulates graft-versus-host disease (GVHD) and facilitates engraftment of allogeneic bone marrow (BM).
    Taylor PA; Panoskaltsis-Mortari A; Freeman GJ; Sharpe AH; Noelle RJ; Rudensky AY; Mak TW; Serody JS; Blazar BR
    Blood; 2005 Apr; 105(8):3372-80. PubMed ID: 15618467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR; Taylor PA; Panoskaltsis-Mortari A; Sharpe AH; Vallera DA
    J Immunol; 1999 Jun; 162(11):6368-77. PubMed ID: 10352249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strong CD28 costimulation suppresses induction of regulatory T cells from naive precursors through Lck signaling.
    Semple K; Nguyen A; Yu Y; Wang H; Anasetti C; Yu XZ
    Blood; 2011 Mar; 117(11):3096-103. PubMed ID: 21245484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of STAT3 in CD4+CD25+FOXP3+ regulatory lymphocyte generation: implications in graft-versus-host disease and antitumor immunity.
    Pallandre JR; Brillard E; Créhange G; Radlovic A; Remy-Martin JP; Saas P; Rohrlich PS; Pivot X; Ling X; Tiberghien P; Borg C
    J Immunol; 2007 Dec; 179(11):7593-604. PubMed ID: 18025205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effects of B7-1 and B7-2 on the costimulation of mouse nonspecific cytotoxic T lymphocyte development in response to anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Hoskin DW
    J Leukoc Biol; 1999 Nov; 66(5):792-802. PubMed ID: 10577511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretion.
    Ueda Y; Levine BL; Huang ML; Freeman GJ; Nadler LM; June CH; Ward SG
    Int Immunol; 1995 Jun; 7(6):957-66. PubMed ID: 7577804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costimulation light: activation of CD4+ T cells with CD80 or CD86 rather than anti-CD28 leads to a Th2 cytokine profile.
    Broeren CP; Gray GS; Carreno BM; June CH
    J Immunol; 2000 Dec; 165(12):6908-14. PubMed ID: 11120816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single CD28 stimulation induces stable and polyclonal expansion of human regulatory T cells.
    He X; Smeets RL; van Rijssen E; Boots AM; Joosten I; Koenen HJ
    Sci Rep; 2017 Feb; 7():43003. PubMed ID: 28223693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligation of OX40 (CD134) regulates graft-versus-host disease (GVHD) and graft rejection in allogeneic bone marrow transplant recipients.
    Blazar BR; Sharpe AH; Chen AI; Panoskaltsis-Mortari A; Lees C; Akiba H; Yagita H; Killeen N; Taylor PA
    Blood; 2003 May; 101(9):3741-8. PubMed ID: 12521997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute graft-versus-host disease without costimulation via CD28.
    Speiser DE; Bachmann MF; Shahinian A; Mak TW; Ohashi PS
    Transplantation; 1997 Apr; 63(7):1042-4. PubMed ID: 9112366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD28/B7 regulation of anti-CD3-mediated immunosuppression in vivo.
    Tang Q; Smith JA; Szot GL; Zhou P; Alegre ML; Henriksen KJ; Thompson CB; Bluestone JA
    J Immunol; 2003 Feb; 170(3):1510-6. PubMed ID: 12538715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of B7-dependent responses in CD28-deficient mice.
    Green JM; Noel PJ; Sperling AI; Walunas TL; Gray GS; Bluestone JA; Thompson CB
    Immunity; 1994 Sep; 1(6):501-8. PubMed ID: 7534617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.